FDA approves Aegerion's cholesterol drug with strongest warning

(Reuters) - Aegerion Pharmaceuticals Inc said the U.S. health regulator approved its drug as an alternative treatment for patients who have a genetic predisposition to high cholesterol.

san diego nightlife windows office 2010 upper west side restaurants